P65 Adjuvant management of operated uterine sarcomas: a single institution experience. (1st November 2019)
- Record Type:
- Journal Article
- Title:
- P65 Adjuvant management of operated uterine sarcomas: a single institution experience. (1st November 2019)
- Main Title:
- P65 Adjuvant management of operated uterine sarcomas: a single institution experience
- Authors:
- Cordoba, A
Prades, J
Basson, L
Robin, Y-M
Taieb, S
Narducci, F
Hudry, D
Bresson, L
Chevalier, A
Le Tinier, F
Mirabel, X
Lartigau, E
Penel, N
Leblanc, E - Abstract:
- Abstract : Introduction/Background: Describe the adjuvant management of high grade Uterine Sarcoma (US) and highlight prognostic factors for overall survival (OS) and pelvic-free survival (PFS). Methodology: Between 01/2000 and 01/2015, 91 patients undergoing surgery were presented at the Multidisciplinary Team Meeting of our institution. The type of surgery, the anatomopathological features, adjuvant treatments, dates and sites of recurrence were collected. The prognostic value of the various factors was evaluated with the multivariate Cox model. Results: A total of 50 women were identified including 43 (86%) leiomyosarcomas and 7 (14%) high grade sarcoma. 18 (36%) patients received adjuvant pelvic radiotherapy (AR) and 6 (12%%) received adjuvant systemic therapy. The median follow-up time was 63 months. 39 (78%) patients had a recurrence: 22 (58%) only metastatic recurrence, 2 (5%) isolated pelvic recurrence and 15 (38%) pelvic and metastatic recurrence. AR (p=0.005, HR=0, 15) was associated with survival without pelvic recurrence in univariate analysis; age >55 years (p=0.015, HR=2.37) and AR (p=0.013, HR=0.41) were associated with metastatic free survival in multivariate analysis. Conclusion: According to the results of our series, there is a benefit of radiotherapy after surgery in terms of local control of US. It is necessary to identify the subgroup of patients who will benefit from an AR in order to provide them with more optimal care. Disclosure: The authors declareAbstract : Introduction/Background: Describe the adjuvant management of high grade Uterine Sarcoma (US) and highlight prognostic factors for overall survival (OS) and pelvic-free survival (PFS). Methodology: Between 01/2000 and 01/2015, 91 patients undergoing surgery were presented at the Multidisciplinary Team Meeting of our institution. The type of surgery, the anatomopathological features, adjuvant treatments, dates and sites of recurrence were collected. The prognostic value of the various factors was evaluated with the multivariate Cox model. Results: A total of 50 women were identified including 43 (86%) leiomyosarcomas and 7 (14%) high grade sarcoma. 18 (36%) patients received adjuvant pelvic radiotherapy (AR) and 6 (12%%) received adjuvant systemic therapy. The median follow-up time was 63 months. 39 (78%) patients had a recurrence: 22 (58%) only metastatic recurrence, 2 (5%) isolated pelvic recurrence and 15 (38%) pelvic and metastatic recurrence. AR (p=0.005, HR=0, 15) was associated with survival without pelvic recurrence in univariate analysis; age >55 years (p=0.015, HR=2.37) and AR (p=0.013, HR=0.41) were associated with metastatic free survival in multivariate analysis. Conclusion: According to the results of our series, there is a benefit of radiotherapy after surgery in terms of local control of US. It is necessary to identify the subgroup of patients who will benefit from an AR in order to provide them with more optimal care. Disclosure: The authors declare that they have no potential conflict of interest relevant to this article. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 4
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 4
- Issue Display:
- Volume 29, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2019-0029-0004-0000
- Page Start:
- A96
- Page End:
- A96
- Publication Date:
- 2019-11-01
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-ESGO.127 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19762.xml